Effect of probiotics on allergic rhinitis in children; A systematic review and meta-analysis

Aida Bakhshi1,2, Farid Poursadegh3, Moeen Salari4

  • 1Clinical Research Development Unit, Faculty of Medicine, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

Probiotics significantly improved nasal and eye symptoms and quality of life for children with allergic rhinitis (AR). However, results showed considerable variation, suggesting a potential adjunctive role requiring further high-quality research.

Area of Science:

  • Pediatric Allergy and Immunology
  • Gastroenterology
  • Microbiome Research

Background:

  • Allergic rhinitis (AR) is a common childhood condition impacting quality of life and increasing comorbidity risk.
  • Probiotics are explored for their immunomodulatory potential in allergic diseases.
  • This review assesses probiotic efficacy for pediatric AR.

Purpose of the Study:

  • To evaluate the efficacy of probiotics versus placebo in managing pediatric allergic rhinitis.
  • To analyze clinical and laboratory outcomes in children with AR receiving probiotic interventions.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials (RCTs).
  • Searches across major databases (PubMed, Web of Science, Scopus, Embase) up to April 2025.
  • Inclusion of RCTs in children (<18 years) comparing probiotics/prebiotics/synbiotics to placebo, analyzing clinical and lab parameters using random-effects models.

Main Results:

  • Fourteen RCTs with 1,739 children were analyzed.
  • Significant reductions in nasal symptom scores (SMD = -1.40) and eye symptom scores (SMD = -3.59) were observed.
  • Quality of life (RQLQ) significantly improved (SMD = -2.98), with a minor increase in serum eosinophils (SMD = 0.29).

Conclusions:

  • Probiotics demonstrated benefits for nasal/ocular symptoms and quality of life in pediatric AR.
  • Findings should be interpreted cautiously due to substantial heterogeneity.
  • Further standardized, high-quality trials are necessary to confirm probiotics' role as adjunctive therapy.
Abstract

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Reactions02:06

Allergic Reactions

Overview
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.